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Mutations in the gene CLN3 are responsible for the neurodegenerative disorder juvenile neuronal ceroid lipo-
fuscinosis or Batten disease. CLN3 encodes a multi-spanning and hydrophobic transmembrane protein
whose function is unclear. As a consequence, the cell biology that underlies the pathology of the disease
is not well understood. We have developed a genetic gain-of-function system in Drosophila to identify func-
tional pathways and interactions for CLN3. We have identiﬁed previously unknown interactions between
CLN3 and the Notch and Jun N-terminal kinase signalling pathways and have uncovered a potential role
for the RNA splicing and localization machinery in regulating CLN3 function.
INTRODUCTION
Juvenile neuronal ceroid lipofuscinosis (JNCL or Batten
disease) is the most common of the NCLs, a collection of neu-
rodegeneration disorders affecting children (1,2). In JNCL,
retinal degeneration manifests at age 5–7 years usually fol-
lowed by seizures and a progressive loss of motor skills and
mental acuity. JNCL is invariably fatal, with death occurring
usually by 25 years. Histopathologically, post-mortem brain
material from JNCL patients shows widespread neuronal
loss with accompanying gliosis (reviewed in 3). Common to
all NCLs, both neuronal and peripheral tissues from JNCL
patients show extensive accumulations of lysosomal storage
material, indicative of some form of lysosomal dysfunction.
Consequently, the NCLs are included in the larger family of
metabolic disorders, the lysosomal storage disorders (4).
JNCL is an autosomal recessive disorder resulting from
mutations in the gene CLN3 that encodes a multi-spanning
transmembrane protein (5,6). CLN3 is expressed widely and
many cell types from JNCL patients display lysosomal
storage material. However, only neuronal pathology is seen:
either the CLN3 protein has a function unique to neurons or
neurons are particularly susceptible to loss of CLN3. Although
major progress has been made using mouse models to examine
the disease progression (7–10), our understanding is currently
restricted by a lack of knowledge about the functions of, and
even the precise location of, the CLN3 protein within cells.
Various approaches have been used to study the cell biology
of CLN3. In vitro studies using CLN3 mutant cell lines gener-
ated from mouse models and human patients have suggested
roles for CLN3 in many cellular processes including intracellu-
lar trafﬁcking, endocytosis, apoptosis, autophagy and lipid
cycling (reviewed in 3). Yeast strains mutant for the CLN3
homologue, BTN1, have also proved valuable: Saccharomyces
cerevisiae and Schizosaccharomyces pombe mutant strains
both show elevated vacuolar pH (11,12), whereas S. cerevisiae
strains are defective in arginine transport into the vacuole,
resulting in a disruption in nitric oxide metabolism (13–15).
However,thesevariedapproaches havefailedtoproduceacon-
sensus on the function of CLN3. Progress has also been ham-
pered by the highly hydrophobic nature of the CLN3 protein
that makes conventional biochemical approaches difﬁcult and
by the fact that it is seemingly expressed at low levels. There
is a need for new model systems to study CLN3 biology and
function to further our understanding of the disease. In particu-
lar, systems are required that will identify functional pathways
without relying on biochemical techniques. Identifying such
pathwaysmayinturnrevealnoveltherapeutictargetsforJNCL.
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Advance Access published on November 21, 2008The fruit ﬂy Drosophila is an attractive model system for
studying neuronal function and neurodegeneration because
of its relatively simple nervous system, the powerful genetic
tools available and the ability to study neuronal and synapse
biology at high resolution (reviewed in 16,17). Several
human neurodegenerative disorders have been modelled suc-
cessfully in Drosophila, including congenital and infantile
forms of NCL (18,19). Here we describe the Drosophila hom-
ologue of CLN3 and introduce gain-of-function genetic
approaches to identify pathways that require CLN3 function
and novel interactions for CLN3. We demonstrate that
ectopic CLN3 expression inhibits Notch signalling but acti-
vates the Jun N-terminal kinase (JNK) signalling pathway
and identify novel and unexpected genetic interactions with
a regulator of RNA translation, stability and localization.
RESULTS
Juvenile NCL is an autosomal recessive disorder caused by
mutations in the gene CLN3 (5). The protein encoded is a
multi-spanning transmembrane protein, the topology of
which remains unclear. The most recent prediction based on
a model constrained by experimental data suggests six trans-
membrane spans with both the N- and C-termini resident in
the cytosol (20). The Drosophila genome encodes one likely
orthologue—CG5582 at position 75A2. Sequence alignments
show strong conservation with vertebrate CLN3 proteins in
the predicted transmembrane regions, in the lumenal loops
and in the C-terminal region thought to be intracellular (Sup-
plementary Material, Fig. S1). Both lysosomal targeting
sequences identiﬁed experimentally in the human protein are
conserved in Drosophila CLN3.
Drosophila CLN3 localizes to lysosomes, the plasma
membrane and recycling vesicles
The exact localization of CLN3 remains undeﬁned despite
examination of its distribution in a number of studies
(reviewed in 21). Owing to the absence of appropriate speciﬁc
antisera, most studies have employed overexpression and
epitope-tagging to get an indication of localization in cultured
cells and neurons. A similar approach was used to examine the
distribution of Drosophila CLN3 in cells. An N-terminal
GFP-CLN3 construct was expressed in HEK293 cells and its
distribution compared with various markers of cellular com-
partments and with that of the human CLN3. Like the
human protein, the distribution of Drosophila CLN3 partially
overlaps with that of LAMP1, a marker for late endosomes
and lysosomes [compare Fig. 1A and B; (22,23)]. At higher
expression levels, CLN3 is also seen on the plasma membrane
(data not shown). Strong co-localization was also seen in a
subset of transfected cells with anti-Rab11, particularly
in large vesicles in the periphery of the cells (Fig. 1C), sup-
porting previous data (24). Rab11 regulates the recycling of
vesicles from the perinuclear recycling compartment to the
plasma membrane, suggesting that CLN3 may be a component
of, or trafﬁcked by, these vesicles. No signiﬁcant
co-localization was seen with markers of other compartments
or endosomes (data not shown).
CLN3 overexpression in the eye leads to degeneration
Our understanding of CLN3 cell biology would be aided signiﬁ-
cantly if more of the signalling pathways and molecules that
interact with CLN3 were known. The highly hydrophobic
nature of the CLN3 protein means that some of the commonly
used biochemical approaches for identifying interactions can be
difﬁcult. To overcome this problem, we decided to develop a
strategy that would allow us to identify interacting molecules
and functional signalling pathways using genetic approaches.
We generated transgenic ﬂies to express CLN3 under the
control of the bipartite GAL4-UAS system that allows for
highly regulated tissue-speciﬁc expression (25). We were then
able to examine the phenotypic consequences of increasing
levels of CLN3 function during organ and tissue development
inthe ﬂy. Thesephenotypes were causedbya moderate increase
intheexpressionofCLN3;forexample,inourexperiments,inthe
wing,weestimatethatthelevelsofCLN3areincreased2.86-fold
(+0.42SD)overbasallevelsofCLN3expression(seeMaterials
and Methods). Finally, we were able to use genetics to identify
pathways and molecules that affect these phenotypes.
Initially,wedecidedtofocusonoverexpressioninthedevelop-
ing ﬂy eye. The development of the eye is heavily dependent on
endocyticandvesicletrafﬁckingevents(26–28),bothsuggested
functions for CLN3. Expression of CLN3 in the eye produced a
signiﬁcant glazing of the compound eye indicative of degener-
ation (Fig. 2A versus B and C). The severity of the phenotype
varied between lines, presumably reﬂecting differing levels of
expression of the CLN3 transgene from different chromosomal
locations. Expression of a YFP-CLN3 fusion produced a similar
phenotype (Fig. 2D), as did the expression of human CLN3
Figure 1. Localization of Drosophila CLN3 in HEK293 cells. N-terminal
fusions of human (Hs) or Drosophila (Dm) CLN3 to GFP were expressed in
cells and their distributions detected with an antibody to GFP (middle
panels, green in merge). Lysosomes and late endosomes were detected with
anti-LAMP, recycling vesicles with anti-Rab11 (left panels, red in merge).
(A and B) Both human and Drosophila CLN3 partially co-localizes with
LAMP1. (C) In a subset of cells, Drosophila CLN3 is seen to co-localize
with Rab11-positive vesicles at the periphery of cells (arrowhead). Bar: 5 mm.
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regular crystallinearray ofommatidia, fusions ofommatidiaand
alterationsinbristlepatterns(Fig.2EversusF).Sectionsthrough
the eyes show an extensive degeneration (Fig. 2G versus H). To
conﬁrm that this phenotype is speciﬁc to CLN3 overexpression,
we also overexpressed the lysosomal proteins, LAMP and spin-
ster,andthelateendosomalprotein,Hook,intheeye.Thesecon-
trols displayed no phenotype, suggesting the CLN3 phenotypes
arespeciﬁcandnotaconsequenceofoverloadingtheendosomal-
lysosomal membrane system (data not shown).
The external glazing of the Drosophila eye can be caused by
widespread apoptosis during eye development. However, in this
case, blocking apoptosis by co-expressing the baculovirus
inhibitor p35 (29) failed to rescue the phenotype (Fig. 2I),
suggesting apoptosis is not the primary cause. Co-expression
of an RNAi construct designed for CLN3 knockdown did
revert the phenotype back towards wild-type, indicating that
the initial phenotype is speciﬁcally because of the overexpres-
sion of CLN3 (Fig. 2J).
Notch-like phenotype resulting from overexpression of
CLN3
Having observed strong phenotypes in the eye, CLN3 was
expressed ubiquitously throughout Drosophila development
or selectively in imaginal tissues which give rise to particular
structures of the adult ﬂy during metamorphosis. In both cases,
phenotypes reminiscent of Notch loss-of-function resulted
(28). Ubiquitous overexpression using the daughterless Gal4
driver was semi-lethal. Escaping adults were noticeably
smaller than controls (Supplementary Material, Fig. S2) and
displayed roughened eyes (compare Fig. 3A versus B; overex-
pression denoted by da.cln3). Overexpression also led to
duplication of macrochaetae (the larger sensory bristles) on
the thorax of the adult ﬂy (Fig. 3C versus D, boxed region
enlarged in Fig. 3D0). Wings displayed thickened veins
(compare veins in Fig. 3G versus H), vein deltas and
notches in the wing margin (Fig. 3H).
Using different Gal4 driver lines to express CLN3 in subsets
of cells in the developing ﬂy resulted in similar phenotypes.
Expression driven by dppGal4 driver resulted in duplications
in the sternopleural bristles on the side of the adult ﬂy
(Fig. 3E versus F, bristles circled, denoted dpp.cln3).
Finally, expression driven along the wing margin under the
control of the VgM gal4 line caused large notches to appear
in the wing blade (Fig. 3I, arrowheads, denoted VgM.cln3).
Taken together, these phenotypes strongly suggest that overex-
pression of CLN3 leads to loss of Notch function. Notch acts
as a receptor for the Delta/Serrate/LAG-2 ligand family
which functions in a variety of contexts to allow communi-
cation between cells whereby transcription of target genes
are activated in the Notch expressing cell. This signalling
pathway requires proteolytic cleavage of the Notch receptor
and its endocytosis into the cell (reviewed in 30).
If Notch signalling was indeed affected by CLN3 overex-
pression, we reasoned that introducing a mutant allele of the
Notch ligand, Delta, should enhance the effect. We focused
on duplication of the macrochaetae on the scutellum of the
adult ﬂy. In control ﬂies, there are invariably 4.0 macrochaetae
(n ¼ 26, see Materials and Methods for genotypes). When
CLN3 was overexpressed in the posterior of the imaginal
wing disc using the engrailed GAL4 driver, duplications of
one or more of the bristles were common and the mean
number of macrochaetae per scutellum increased to 4.65
(n ¼ 17). When CLN3 was overexpressed in a genetic back-
ground heterozygote for a strong allele of Delta, the frequency
of duplication increased further to a mean of 6.29 macrochae-
tae per scutellum (n ¼ 24, P , 0.0001). These data indicate
that the Notch signalling pathway does interact geneti-
cally with the gain-of-function phenotypes seen with CLN3
overexpression.
Several of the phenotype described earlier can also result
from alterations in EGF, BMP and other signalling pathways
(31). To demonstrate further that that CLN3 overexpression
does indeed inhibit Notch signalling, transcription of the cut
gene was used as readout for the Notch pathway. cut
encodes a homeodomain protein structurally related to
human CDP and mouse cux proteins (32). cut is transcribed
in a narrow strip of cells at the dorsal–ventral margin of
the developing Drosophila imaginal wing disc, and this tran-
scription requires Notch activity (33). We made use of the
fact that dppGal4 drives expression along the anterior–
posterior compartment boundary of the wing disc which inter-
sects at only one region with the dorsal–ventral stripe of cut
expression. This is demonstrated in Figure 4A, where a
Figure 2. Overexpression of CLN3 in the developing Drosophila eye results in
degeneration. (A–D) Light micrographs of eyes from adult ﬂies. (A) Control
eye (GMRgal4/þ); (B and C) Overexpression of CLN3 at lower (B) and
higher (C) levels under the control of the eye-speciﬁc GMRgal4 causes
glazing and loss of tissue (both denoted GMR.cln3). (D) Overexpression
of a VenusYFP-CLN3 fusion results in a similar phenotype. (E and F) SEM
of the surface of adult eyes. (E) Control eyes show a regular array of omma-
tidia. (F) Overexpression of a VenusYFP-CLN3 fusion results in misshapen
and fused ommatidia (denoted GMR.VenusCln3).( G and H) Sections of
adult retinas. (G) In control retinas, ommatidia-containing groups of dark
staining photoreceptors are arrayed evenly. (H) Overexpression of CLN3
(denoted GMR.CLN3) results in disruption to ommatidial organization and
widespread vacuolation indicative of degeneration (asterisks). (I) The princi-
pal eye phenotype is not due to apoptosis, as co-expression of the baculovirus
apoptosis inhibitor, p35, with CLN3 does not rescue the phenotype. (J) The
eye phenotype is suppressed by co-expression of dsRNA construct targeting
CLN3 (denoted cln3IR), indicating that it is due to CLN3 overexpression.
(K) Overexpression of human CLN3 results in a similar phenotype
(GMR.Hs cln3).( L) Overexpression of a C-terminally truncated form of
CLN3 shows no phenotype (GMR.cln3DC).
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dppGal4 (dpp.CD8::GFP). Discs were processed to visualize
GFP (green) and Cut protein (red). The overlapping regions of
expression are circled in the merged panel. When CLN3 was
overexpressed under the control of dppGal4 (dpp.CLN3), a
clear loss of Cut protein was seen at the intersection of the
expression domains, indicating a loss of Notch activity
(Fig. 4B, arrow).
To try to understand the mechanism of inhibition of Notch,
a full-length Notch construct was co-expressed with CLN3.
This construct failed to reconstitute the Cut stripe fully
(Fig. 4C, arrow), indicating that the inhibition is likely to be
at the level of the Notch protein function rather than its
expression. This was conﬁrmed by immunostaining for
Notch protein which indicated no changes in Notch protein
levels in the wing disc where CLN3 was expressed (data not
shown). We also asked whether CLN3 overexpression was
actually inhibiting downstream targets of Notch transcription,
rather than Notch itself. Notch is cleaved upon ligand binding,
releasing the intracellular part of the protein which translo-
cates to the nucleus to act on transcription. The Notch
intra con-
struct does not require ligand binding or cleavage and so acts
as a dominant active molecule (34). Co-expression of this con-
struct alongside CLN3 restored cut transcription and also
induced ectopic cut elsewhere along the dppGal4 domain of
expression (Fig. 4D). Clearly, the cells expressing CLN3
remain competent for signalling downstream of Notch.
Activation of JNK signalling by CLN3
Mutants that affect Notch glycosylation or cleavage cause a
global inhibition of Notch function, for examples, see refer-
ences (35,36). These mutants display neurogenic phenotypes
in embryos and duplications of the smaller sensory bristles
(the microchaetae) on the thorax in addition to the types of
phenotypes described earlier. CLN3 overexpression does not
affect microchaetae (Fig. 3D and D0) and there is no neuro-
genic phenotype (data not shown). Hence, the mechanism of
inhibition is unlikely to be via these processes but we con-
sidered that elucidating the mechanism might shed light on
normal CLN3 function. We focused on two observations that
suggested CLN3 may inhibit Notch via activation of JNK
signalling.
Figure 3. Notch-like phenotypes in Drosophila overexpressing CLN3.( A–D) SEM of Drosophila eyes and thoraces. (A and C) Control ﬂies (daGal4/þ) display
a regular crystalline array of ommatidia in the eye and individual macrochaetae on the thorax. (B and D) Overexpression of CLN3 (denoted da.cln3) leads to a
roughening of the eye and multiple duplications of the macrochaetae (boxed region enlarged in D0). The microchaetae on the thorax are unaffected. (E and F)A
similar duplication of the sternopleural bristles is seen when CLN3 is overexpressed with the dppGal4 driver (dpp.cln3, bristles circled). Overexpression of
CLN3 also causes Notch-like phenotypes in the adult wing. (G) Control wing. (H) Overexpression throughout the wing (da.cln3) causes thickening of
veins, vein deltas (arrowhead) and notching in the margin (arrow). (I) Overexpression in the wing margin (VgM.cln3) leads to signiﬁcant notching (arrows).
Figure 4. Loss of Notch activity in the developing wing. (A) dppGal4 drives
expression of membrane-tethered CD8::GFP in a stripe along the A-P com-
partment boundary (left panel and green in merge). This stripe intersects
with the restricted expression of the Notch transcriptional target, cut (middle
panel and red in merge, intersecting region circled). (B) When CLN3
expression is driven by dppGal4, cut expression is lost at the intersection, indi-
cating loss of Notch transcriptional activity (arrow). (C) Co-expression of a
full-length Notch construct fails to rescue cut expression completely
(arrow). (D) Co-expression of the dominant active Notch intracellular
domain (Notch
intra) rescues cut expression and also induces ectopic cut
expression along the A-P boundary (bracketed). Posterior is right. Bar: 10 mm.
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dorsalmidlineledtodorsalclosurephenotypesinboththethorax
(Fig. 5A versus B) and the abdomen (Fig. 5C versus D) of adult
ﬂies. In both the embryo and during metamorphosis, the dorsal
surface is closed by migration of epithelia towards the midline
and subsequent fusion. Dorsal closure phenotypes are character-
istic of mutations in components of the JNK signalling pathway
(37–39).Importantly,apreviousstudyhasreportedgeneticinter-
actionsindorsal closureevents between Notch and bsk (the Dro-
sophila homologue of JNK). In dorsal closure events, increased
levels of phospho-JNK are seen in Notch mutants, suggesting
crosstalkbetweenthetwosignallingpathways(40).Themechan-
ismisnotknown,althoughtheinteractionappearstobeindepen-
dent of ligand binding to Notch.
Second, we observed that CLN3 overexpression caused an
induction of apoptosis in the developing wing disc (Fig. 5E
and F). Activation of JNK signalling can commonly lead to
apoptosis (reviewed in 41). Apoptotic cells were identiﬁed
through expression of a reporter for caspase activity—a
membrane-tethered CD8::PARP fusion protein (42). In apop-
totic cells, PARP is cleaved by caspases and this event can
be detected with an antibody speciﬁc to the cleaved form.
We expressed the PARP reporter with or without CLN3 in
the posterior half of the developing wing disc using the
engrailed GAL4 driver. Few apoptotic cells were visible in
wing discs expressing the reporter alone (Fig. 5E). In contrast,
when CLN3 was co-expressed, a large increase in apoptosis
was seen (Fig. 5F), especially in the wing pouch.
Taken together, these data suggested that CLN3 overexpres-
sion may affect JNK signalling, but to examine this more
directly, we looked for genetic interactions between the two.
Overexpressing CLN3 in the posterior half of the wing disc
during development leads to thickened veins and notches in
the posterior half of adult wings (Fig. 5G versus H, posterior
half shown below the dashed line in H). In contrast, overex-
pressing either the Drosophila JNK homologue encoded by
bsk (en.UAS-bsk) or a dominant negative JNK (bskDN) con-
struct has no effect on the wing (Fig. 5G and data not shown).
However, expressing both CLN3 and bsk leads to a dramatic
Figure 5. CLN3 interacts genetically with and ectopically activates JNK sig-
nalling. Thoraces and abdomens of adult Drosophila.( A and C) Control
thorax and abdomen. (B and D) Overexpression of CLN3 along the dorsal
midline by pnr-Gal4 leads to dorsal closure defects in the thorax (B) and
abdomen (D), indicating a possible affect on JNK signalling. (E and F)
CLN3 expression increases apoptosis in the wing disc. To visualize apoptosis,
a CD8::Venus::PARP membrane-tethered probe for caspase activity was
expressed in the posterior half of third instar wing discs (CD8 immunostain-
ing, left panels and green in merge). The PARP probe is cleaved by active cas-
pases, so apoptotic cells can be detected with an antibody speciﬁc to the
cleaved form of PARP (cleaved PARP, middle panels and red in merge).
(E) Few apoptotic cells are seen when the probe is expressed alone. (F)
Co-expression of the probe with CLN3 leads to a large increase in apoptosis,
particularly in the central wing pouch region (middle panels). Posterior is
right. Bar: 5 mm. (G–J) Expression of bsk,aDrosophila JNK, enhances the
effect of CLN3. (G) Expression of bsk in the posterior half of the wing
(below dashed line, denoted en.UAS-bsk) does not alter the morphology.
(H) Expression of CLN3 in the posterior half (en.UAS-cln3) leads to
thickened veins, vein deltas (arrowhead) and loss of tissue. (I) Co-expression
of CLN3 with bsk leads to almost complete loss of tissue in the posterior half,
indicating a strong genetic interaction (en.UAS-cln3þUAS-bsk). (J)
Co-expression of a dominant negative bsk construct (UAS-bskDN) with
CLN3 leads to vein truncations and clones of cells with multiple bristles in
the posterior half of the wing (boxed area enlarged in J0). (K) Co-expression
of CLN3 with hep (a Drosophila JNKK) also enhances the CLN3 phenotype
(en.UAS-hep,UAS-cln3). (L and M) Overexpression of CLN3 leads to
ectopic activation of JNK signalling. puc-lacZ was used as reporter for acti-
vated JNK signalling (b-Gal, middle panels and red in merge). (L) Control
wing discs show little JNK activity. (M) Overexpression of CLN3 in the pos-
terior half (CLN3, left panels and green in merge) results in a dramatic ectopic
activation of JNK signalling (M). Posterior is right. Bar: 5 mm.
Human Molecular Genetics, 2009, Vol. 18, No. 4 671increase in phenotype, with almost complete loss of tissue in
the posterior half suggesting extensive apoptosis and demon-
strating a strong genetic interaction (en.UAS-bsk,UAS-cln3,
Fig. 5I). Co-expression of CLN3 and bskDN produces clones
of cells in the wings with multiple bristles (en.-
UAS-bskDN,UAS-CLN3, Fig. 5J and boxed region enlarged
in 5J0). Presumably, these are cells with complete inhibition
of Notch function that would usually die but are rescued
from apoptosis by dominant negative JNK. Co-expression of
hep, the Drosophila JNKK, also enhanced the CLN3 overex-
pression phenotype (en.UAS-hep,UAS-cln3, Fig. 5K).
We next examined direct effects of CLN3 overexpression on
JNKsignallingitselfinthewing disc.Usingapuc-lacZreporter
as a readout for JNK-signalling activity (39), ectopic activation
of JNK signalling could clearly be seen in the posterior half of
wing discs when CLN3 was overexpressed in that compartment
[Fig. 5L versus M, compare anterior (left) and posterior (right)
compartments]. This activation of JNK signalling does not
appear to be due to an increase in JNK levels but rather an
increase in active JNK, as there is no observable increase in
JNK protein levels in the CLN3 overexpressing cells (data not
shown). In contrast, in a similar experiment, CLN3 overexpres-
sion had no effect on EGF receptor signalling in the posterior
half of wing discs, visualized using an argos-lacZ reporter
(data not shown). It therefore seems unlikely that the activation
of JNK signalling is due to a generalized effect on ligand–
receptor complex trafﬁcking or degradation.
Dominant modiﬁcation of the CLN3 overexpression eye
phenotype
Alterations of the appearance of the Drosophila eye and wing
are commonly used for genetic screens. Neither organ is
essential for viability, and modiﬁcations of the phenotype
are easily scoreable. We tested the feasibility of using the
degenerative eye and phenotype caused by overexpression of
CLN3 as the basis of a screen to identify dominant genetic
interactions. Brieﬂy, a collection of deﬁned chromosomal
deﬁciencies, each with a group of genes deleted, were mated
individually to ﬂies overexpressing CLN3 in the developing
eye. In each case, the progeny resulting from the cross carry
only half the gene dosage for each gene lying within the
deﬁciency. The progeny were then scored for modiﬁcation
of the starting phenotype: either a reversion back towards
wild-type or a more severe phenotype. Modiﬁcation indicates
that one of the genes whose dose has been reduced interacts
genetically with CLN3. A combination of the DrosDel collec-
tion of deﬁned deﬁciencies and lines from the Bloomington
Stock Centre deﬁciency kits were used to screen the large
majority of the two main Drosophila autosomes. As expected,
the deﬁciency that deletes the CLN3 locus suppressed the eye
phenotype by reducing the gene dosage. In addition, ﬁve other
deﬁciencies caused signiﬁcant suppression of the phenotype
and four deﬁciencies caused signiﬁcant enhancement
(Fig. 6A–D and Supplementary Material, Table S1).
Identiﬁcation of a novel genetic interactions between CLN3
and an RNA-binding protein
The deﬁciency Df(2R)ED3791 that dominantly enhanced the
eye phenotype (Fig. 6D) was selected for further study to
identify the gene responsible. The ED3791 deﬁciency
deletes 79 genes. The same mating strategy was repeated
using smaller overlapping deﬁciencies within the same
region. One Df(2R)F36 that deletes only nine genes similarly
enhanced the eye degeneration (data not shown). Sub-
sequently, alleles of one of the nine genes, mago nashi, dis-
played a similar dominant enhancement when the gene
dosage was halved (Fig. 6E–H), indicating that it was the
gene responsible. mago nashi alleles also showed dominant
enhancement of the wing phenotypes caused by CLN3 overex-
pression (Fig. 6J versus K). mago nashi alleles did not show a
dominant phenotype with the GMRgal4 driver alone in the
absence of CLN3 overexpression (data not shown).
This discovery highlights the power of this CLN3
gain-of-function system for identifying novel and unexpected
interactions: mago nashi encodes a highly conserved com-
ponent of the exon–exon junction complex (EJC) that regu-
lates RNA stability and has roles in RNA and organelle
transport and cell polarity in many systems (43). Mago nashi
functions as a dimer with Tsunagi/Y14 (44,45). An allele of
tsunagi also enhances the CLN3 overexpression eye phenotype
Figure 6. Components of the EJC interact genetically with CLN3.( A–D)
Light micrographs of adult Drosophila eyes. (A) Wild-type eye. (B) Degener-
ation in the eye due to overexpression of a VenusYFP fusion with CLN3
(denoted VenusCln3 or V-Cln3). Examples of eyes isolated from a screen of
chromosomal deﬁciencies to identify dominant modiﬁers of the CLN3 overex-
pression phenotype. (C) Deﬁciency Df(3R)3-4 suppresses and (D)
Df(2R)ED3791 enhances the phenotype. The EJC component mago nashi
was shown to be the gene in ED3791 responsible for the enhancement. (E–
H) SEM of adult eyes. (E) mago nashi heterozygote ﬂies show no eye pheno-
type (mago
1/þ). (F) Degeneration caused by overexpression of a
Venus::CLN3 fusion (GMR.V-Cln3). (G and H) Venus::CLN3 overexpres-
sion in ﬂies that are heterozygote for either of two mago nashi alleles enhances
the phenotype and results in the same type of necrosis at the anterior margin of
the eye as in (D). (I) Overexpression of CLN3 in a background heterozygote
for tsunagi/Y14, the dimerization partner of Mago in the EJC results in a
similar enhancement of the phenotype (tsu
D18/þ). (J and K) mago nashi
also interacts genetically with CLN3 in the wing. (J) Expression of CLN3 in
the posterior half of the wing (below the dashed line) results in thickened
veins, deltas (arrowhead), occasionally vein truncations (arrow) and loss of
tissue. (K) The phenotype is enhanced in a mago nashi heterozygote back-
ground. Anterior is left in (A–I) and top in (J and K).
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CLN3.
CLN3-induced phenotypes require a fully functional
protein
The majority of human JNCL patients are homozygous for a
1 kb deletion within the CLN3 gene that is predicted to
encode a protein truncated after the third transmembrane
domain (6). We made use of this truncation to verify that
the phenotypes described earlier are speciﬁc to full-length
CLN3. We generated a human CLN3 construct carrying a
stop codon after amino acid 153 and a Drosophila version
with a stop codon at the equivalent position based on sequence
alignments. There are contrasting views regarding the likeli-
hood that the truncated form of human CLN3 might retain
some functionality in vivo (46,47), so ﬁrst we examined the
distribution of the truncated proteins in HEK293 when
expressed as N-terminal YFP fusions. We argued that for the
truncated forms to retain function, they should localize simi-
larly to the full-length proteins. In contrast to the full-length
YFP-CLN3 fusion proteins (Fig. 1), both the human and
Drosophila truncated forms localized in a reticular pattern
reminiscent of the endoplasmic reticulum (ER) (see Sup-
plementary Material, Fig. S3). These data conﬁrm previous
observations for the human protein (22) and suggest the trun-
cated proteins mis-fold. Although neither construct expresses
the novel 28 amino acids associated with the C-terminus
of the disease-causing CLN3 allele, these are unlikely to
restore the localization. Transgenic ﬂies overexpressing the
truncated forms either untagged or as YFP-fusions failed to
show phenotypes in the eye (Fig. 2L and data not shown) or
in the wing (data not shown). Taken together, these data indi-
cate that the pathways and molecules identiﬁed in these assays
interact with fully functional CLN3.
DISCUSSION
Our understanding of the function of CLN3, the gene disrupted
in JNCL, is poor. Few cellular interactions have been ident-
iﬁed for CLN3 and very little is known of the signalling path-
ways that require CLN3 function. Consequently, the cell
biology underlying the disease remains poorly understood
and options for therapeutic intervention for this fatal disorder
are non-existent. To expand the animal models available to
study CLN3 biology, we describe the characterization of Dro-
sophila CLN3. We ﬁnd that Drosophila CLN3 shows con-
siderable similarity to the human form, with signiﬁcant
stretches of homology and an intracellular location that corre-
sponds to that seen for human CLN3. To begin to identify the
functional pathways within which CLN3 may function, we
have utilized the opportunities provided by Drosophila to
develop a gain-of-function genetic system. This screen has
identiﬁed novel interactions between CLN3 and both Notch
and JNK signalling pathways. Furthermore, we have demon-
strated interactions between CLN3 and an RNA-binding
protein involved in polarity, RNA transport and stability.
Drosophila CLN3 shares many of the properties of human
CLN3
The Drosophila CLN3 protein shows considerable homology
with the human and mammalian forms and can be ﬁtted to
the most current topology predictions. Homology is especially
strong in the predicted transmembrane domains, in the large
second lumenal loop and in the C-terminal intracellular
domain. The Drosophila CLN3 transcript is expressed
throughout the animal (FlyAtlas, www.ﬂyatlas.org), in
common with that observed for mammalian versions of the
gene. When expressed in human HEK293 cells, N-terminally
tagged forms of Drosophila CLN3 protein localize partially
to late endosomes or lysosomes. On occasion, some CLN3
appeared on the plasma membrane and was also localized
within Rab11-positive recycling vesicles. Although Droso-
phila CLN3 is found in the same intracellular compartments
as human CLN3, we consider these results as indicative only
because the CLN3 proteins were both tagged and overex-
pressed. Moreover, fusion of tags to the C-terminus of Droso-
phila CLN3 led to retention of the protein in the ER (data not
shown) as has been reported previously for human CLN3 (22).
An antiserum will be required to conﬁrm the localization of
the endogenous protein in vivo.
The majority of JNCL patients have a 1 kb deletion within
the CLN3 locus that potentially could express a truncated
CLN3 protein. This truncated protein may or may not retain
some function (46,47). Supporting previous ﬁndings (22), we
ﬁnd that similarly truncated forms of either human or Droso-
phila CLN3 protein fail to localize correctly. The proteins
localize into a reticular network, suggesting that they fail to
fold correctly and are retained in the ER.
Although JNCL is a recessive trait generally thought to be
due to a loss-of-gene function, it is possible to identify func-
tional properties of the CLN3 protein by creating a
gain-of-function condition. Overexpresssion of either Droso-
phila or human CLN3 in the developing Drosophila eye
cause neurodegenerative phenotypes, suggesting that both pro-
teins have similar functional properties and activate or inhibit
similar downstream pathways. This neurodegenerative activity
is speciﬁc to the overexpressed gene because the phenotype
caused by the increased Drosophila CLN3 is suppressed by
co-expression of a Drosophila CLN3 RNAi transgene. In
addition, overexpression of the truncated forms of both
human and Drosophila CLN3 does not show any neurodegen-
erative phenotype, suggesting that the observed phenotypes
are produced by the functional protein and that the truncated
versions have lost this activity. It would seem likely, therefore,
that Drosophila CLN3 shares functions with its mammalian
counterpart and will prove to be an excellent model for under-
standing CLN3 cell biology.
Increase in CLN3 activity modiﬁes Notch and JNK
signalling in Drosophila
Drosophila have been used to model a variety of neurodegen-
erative diseases (reviewed in 16,17). Fly models exists for the
infantile and congenital forms of NCL (18,19), whereas Batten
disease-like pathologies are also observed in ﬂies bearing
mutations in spinster/benchwarmer (48). No mutations exist
Human Molecular Genetics, 2009, Vol. 18, No. 4 673in Drosophila CLN3 at present and these will be required to
fully model JNCL in ﬂies. However we can use Drosophila
overexpression as a mechanism to elucidate the types of path-
ways that are affected by an increase in CLN3 activity.
Increased levels of CLN3 cause a neurodegenerative pheno-
type in the Drosophila eye which is similar to, but more
severe than, the phenotype observed when the Drosophila
Cln1 gene DmPPT1 is overexpressed in the same tissue
(49). In the case of DmPPT1, the loss of photoreceptors is
through apoptotic cell death, whereas overexpression of
CLN3 seems to cause neurodegeneration via a process that
does not require apoptosis. Our preliminary evidence suggests
that blocking autophagy also fails to rescue the eye phenotype.
The pathways activated to cause this neurodegeneration are
under current investigation.
We also identiﬁed that when CLN3 is expressed at high
levels in all cells in Drosophila, phenotypes reminiscent of a
loss of Notch activity are observed. This ability of increased
CLN3 to block Notch activity was conﬁrmed by demonstrat-
ing that overexpression of CLN3 in the wing inhibits the acti-
vation of a Notch target gene, cut. This inhibition of Notch is
not rescued by re-expression of full-length Notch but is
rescued by Notch
intra, the active intracellular fragment of
Notch that signals to the nucleus. This suggests that increased
levels of CLN3 might affect the regulation of Notch proces-
sing or cleavage but probably not expression. Interestingly,
we observed Notch inhibition only in certain developmental
contexts, rather than a global inhibition throughout the devel-
opment of the ﬂy, suggesting some degree of cell speciﬁcity.
Notch mutations underlie several human cognitive disorders
and the Notch signalling pathway has been implicated in the
regulation of synaptic plasticity and memory (reviewed in
50,51). Better understood is the major role that Notch signal-
ling plays in a wide variety of developmental processes in
many organ systems, including neurogenesis and gliogenesis,
where Notch regulates decisions of cell fate, differentiation
and stem cell renewal. With the NCLs being early onset dis-
eases, they may have a developmental origin that manifests
itself as an early failure of brain function. Previous studies
have implicated early defects in particular brain regions (7)
and it may be of interest to investigate whether defects in
Notch signalling during development may compromise the
normal function of these regions.
The absence of a global inﬂuence of CLN3 expression on all
Notch signalling led us to investigate whether increased levels
of CLN3 may affect any of the other identiﬁed pathways that
impinge on Notch signalling. Overexpression of CLN3 in
varied cell types gave rise to phenotypes that had been pre-
viously associated with alterations in JNK signalling—apopto-
sis of cells in the developing wing and a failure of dorsal
closure. Signiﬁcantly, crosstalk between the Notch and JNK
signalling pathways has been reported during dorsal closure
(40). We ﬁnd that the phenotypes seen when CLN3 is overex-
pressed are considerably enhanced when the activity of bsk,
the Drosophila JNK, is simultaneously increased by the
co-overexpression of bsk or of the upstream activating regulat-
ory JNK kinase, hep. In addition, overexpression of CLN3
activates the expression of the JNK pathway downstream
target, puckered. These observations are the ﬁrst indication
that CLN3 may play a role in regulating JNK activity and so
places the protein within a major signal transduction
pathway implicated in neuronal disease. JNK signalling is an
important regulator of neuronal apoptosis and differentiation
and aberrant signalling and has been implicated in various
neurodegenerative disorders including Parkinson’s, Alzhei-
mer’s and Huntington’s diseases (reviewed in 52). Support
for the association of JNK signalling pathology with NCL
disease also comes from the Drosophila model for infantile
NCL (INCL), where a gain-of-function screen for modiﬁers
of a neurodegeneration phenotype induced by DmPPT1 ident-
iﬁed misshapen, an upstream kinase in the JNK signalling
pathway, and kayak, the Drosophila fos, a component of
AP1, a major transcription regulator and target of the JNK
pathway (53). The JNK/AP1 pathway has been implicated as
a regulator of synaptic activity, dendritic and synapse
growth (54–56). Although PPT1 and CLN3 encode very
different genes, deﬁcits in their activity lead to INCL and
JNCL, respectively, whose pathologies share many common
features, making it tempting to speculate that aberrations in
JNK signalling may be a common failure leading to synaptic
dysfunction. Similarly, loss of spinster/benchwarmer activity
in Drosophila results in lipofuscin accumulation and produces
synapse growth defects and loss of activity (48,57). It would
be interesting to investigate whether JNK signalling is
altered in loss-of-function mouse models where alterations in
synaptic activity have been speculated to be a possible root
cause of Batten’s disease.
Identiﬁcation of novel CLN3 functional pathways in
Drosophila
We have made use of the neurodegeneration phenotype caused
by overexpression of CLN3 in the Drosophila eye to perform a
non-biasedgeneticscreentoidentifynovelcandidategenesthat
may form part of the CLN3 functional network. This modiﬁer
screen identiﬁes genes that change the phenotypic consequence
of CLN3 overexpression when their gene dosage and activity
are reduced by half. A number of chromosomal deﬁciencies
were identiﬁed that suppress the eye phenotype, suggesting
that genes normally required to generate the degenerative phe-
notype are deleted in these deﬁciencies. Work is ongoing to
identify the individual genes responsible for this suppression.
In addition, we identiﬁed two deﬁciencies that enhance the
CLN3 phenotype. Testing of individual genes in one of these
deﬁciencies identiﬁed that loss of one copy of mago nashi is
responsible for this enhancement and suggesting that the
mago gene product normally acts antagonistically to the path-
ways activated by CLN3. mago encodes a conserved com-
ponent of the EJC that was originally identiﬁed for its role in
generating polarity in the Drosophila oocyte (43,58). In the
absence of mago, there is a failure to transport oskar mRNA
to the posterior of the oocyte, suggesting a requirement for
Mago to localize RNA (58). Mago requires an interaction
with a partner protein Y14/Tsunagi to bind RNA, and a
reduction in tsunagi gene dosage also enhances the CLN3 phe-
notype, suggesting that CLN3 activity inﬂuences or is inﬂu-
enced by a pathway-regulating RNA metabolism. Although
the Mago/Y14 complex is an essential component of the EJC,
it remains unclear whether this splicing role or a role in RNA
localization is the most signiﬁcant function for oogenesis.
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known to be important for synapse function and plasticity
because it allows the rapid local translation of crucial com-
ponents necessary for dendrite/synapse activity. Many of the
components necessary for the localization and translational
control of these neuronal mRNAs are shared with those that
are associated with localized mRNA in the Drosophila
oocyte, e.g. Staufen, Barentsz and FMRP (59). In addition,
Pumilio, a translational repressor also required for the
polarization of the oocyte, has been shown to be associated
with neuronal RNPs (59,60) and is necessary for synapse func-
tion and dendrite morphogenesis (61–63). We have prelimi-
nary evidence that reveals a reduction in pumilio activity
suppresses the effect of overexpression of CLN3 in the wing
(V.V., R.I.T. and G.T. unpublished data). FMRP, the fragile
X mental retardation protein, is also a component of these
RNP granules, and evidence for its possible function has
come from modelling fragile X in Drosophila where overex-
pression in the eye also leads to neurodegeneration (64).
These results lead to the suggestion that CLN3 may participate
in or be regulated by this process of RNA transport. They also
demonstrate why this kind of genetic screen will complement
existing approaches for identifying the functional networks of
CLN3: RNA-binding components of the RNA localization
machinery or translation regulators would be more difﬁcult to
isolateusing,forexample,invitrobinding-oryeast-basedtech-
niques.
We have demonstrated here that Drosophila CLN3 shares
many properties with its human counterpart and that
gain-of-function assay provides a valuable tool for studying
CLN3 cell biology and for identifying novel interactions. In
this study, we have identiﬁed a possible involvement for
CLN3 in the Notch and JNK signalling pathways, and our
dominant modiﬁer screen has identiﬁed a potential role for
the RNA localization machinery in regulating CLN3 function.
These ﬁndings are particularly interesting given that misregu-
lation of both JNK signalling and RNA localization affects
synapse function and has been associated with neurodegenera-
tive diseases. Further work driving expression of CLN3 in
neurons should reveal whether these interactions are important
for neuronal function. In addition, further screens in the eye
and wing are possible on a large scale and will identify
more genetic interactions to direct and instruct future studies
on CLN3 cell biology.
MATERIALS AND METHODS
Drosophila stocks and husbandry
Flies were maintained at room temperature on standard corn-
meal agar medium. All crosses were maintained at 258Co n
standard cornmeal medium or on semi-deﬁned medium
(recipes at Bloomington Stock Centre website) except those
involving dppGal4, which were maintained at 298C.
Drosophila stocks detailed in FlyBase (www.ﬂybase.org).
GMRgal4,vgMgal4, enGal4daGal4andDl
RFwereallsupplied
by the Bloomington Stock Centre. UAS-bsk, UAS-bskDN,
UAS-hep, UAS-p35, UAS-CD8::GFP and puc
E69 were sup-
plied by J. Ng and pnr
MD237 by J. Bateman. The RNAi line to
CG5582 was supplied by the Vienna Drosophila RNAi
Centre. dpp-Gal4, UAS-Notch full length and UAS-Notch
intra
were provided by A. Martinez-Arias. UAS-human CLN3 was
provided by L. Myllykangas. mago
1 was provided by D. St
Johnson. UAS-LAMP-HRP and UAS-Hook-RFP were pro-
vided by H. Kra ¨mer and UAS-Spinster-GFP by S. Sweeney.
UAS-CD8::Venus::PARP was provided by D. Williams.
Deﬁciencies. The dominant modiﬁer screen used predo-
minantly deﬁned deﬁciencies from the DrosDel collection
supplied by the Bloomington and Szeged stock centres. Cyto-
logically deﬁned deﬁciencies from the Bloomington
deﬁciency kits were used to ﬁll coverage gaps.
Unpublished ﬂy stocks. mago
69B and tsu
D18 were gifts from
Drs J.Y. Roignant and J. Treisman (Skirball Institute, NYU
Medical Institute) prior to publication.
Generation of CLN3 expression constructs and transgenic
ﬂies
Entry clones for full-length and truncated forms of Drosophila
CLN3 and human CLN3 were ampliﬁed from cDNA RE03692
and IMAGE clone 5764535 respectively by PCR using Plati-
num Pfx polymerase (Invitrogen) and inserted into pENTR
(Invitrogen). Error-free clones were transferred to pDEST53
(Invitrogen) for HEK293 transfection or to pTW and pTVW
for transgenic ﬂies (Murphy Gateway collection, supplied by
the Drosophila Genetic Resource Center, University of
Indiana) using LR Clonase II (Invitrogen). Transgenic ﬂies
were generated as a service by BestGene Inc., Chino Hills,
CA, USA, using standard procedures and the mini-white
marker mapped to chromosomes using standard mating
schemes.
Cell culture, transfection and immunoﬂuorescence
HEK293 cells were grown in standard DMEMþ10% FBS
(Invitrogen) at 378C, 5% CO2. Cells were subcultured 24 h
prior to transfection and seeded at subconﬂuent density onto
acid-washed coverslips in six-well dishes. One microgram
plasmid was transfected per well using Fugene-6 according
to the manufacturer’s protocol (Roche). Cells were grown
for a further 48 h before ﬁxation. For immunoﬂuorescence,
coverslips were washed once in cytoskeleton buffer (65) and
then ﬁxed for 10 min in 4% EM-grade formaldehyde (Poly-
sciences) in cytoskeleton buffer. After washing in PBS, cells
were permeabilized for 10 min in 0.1% NP-40 (Thermo Scien-
tiﬁc) and then blocked in 1% BSA in PBS for 30 min. Anti-
bodies were diluted in block and applied for 1 h for
primaries or for 45 min for secondaries. After each, coverslips
were washed ﬁve times for 5 min each in PBS with 0.1%
NP-40. Finally, coverslips were mounted in Prolong Gold
(Invitrogen). All immunoﬂuorescence steps were performed
at room temperature.
Wing disc ﬁxation and immunostaining
Third instar Drosophila were dissected in cold cytoskeleton
buffer and ﬁxed for 30 min on ice in 4% EM-grade formal-
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were permeabilized in PBS containing 0.1% Triton X-100
(PBST) and then blocked for 30–60 min in 1% BSA in
PBST. Antibodies were diluted in blocking solution and
applied overnight at 48C on a nutator. Next morning, discs
were washed ﬁve to six times in PBST and then secondary
antibodies applied for 2 h at room temperature. After
washing, discs were transferred to Vectashield (Vector Labs)
and allowed to equilibrate overnight at 48C. Finally, discs
were ﬁne-dissected in Vectashield and transferred to bridge
slides for viewing.
Quantiﬁcation of CLN3 overexpression
An indication of the levels of overexpression of CLN3 was
established by measuring the relative expression levels of
CLN3 driven by enGal4 in the posterior half of wing discs
versus basal levels in the anterior half of the disc. Indirect
immunoﬂuorescence staining with anti-CLN3 was imaged by
confocal microscopy. Nine discs were ﬁxed, processed and
imaged identically. Five-micrometre optical slices was cap-
tured with gain levels set to ensure that all pixel intensities
fell within the 4096 levels of grey detectable. ImageJ software
was used subsequently to measure the mean ﬂuorescence in
30   30 mm
2 areas either side of the compartment boundary.
Background ﬂuorescence due to the secondary antibody was
calculated from discs stained without primary antibody. The
relative overexpression was then calculated as the mean
ratio of posterior:anterior expression.
Antibodies
Primary antibodies and dilutions used: rabbit anti-GFP 1:2000
(Invitrogen); mouse anti-LAMP1 H4A3 1:10 (Developmental
Studies Hybridoma Bank, University of Iowa); mouse
anti-Rab11 (BD Biosciences), 1:500; mouse anti-cut 2B10
1:10 (DSHB); rabbit anti-cleaved PARP 1:500 (AbCam);
chicken anti-bgal 1:2000 (AbCam). Rabbit anti-Drosophila
CLN3 SK4208 was generated as a service by Eurogentec
against two peptides corresponding to amino acids 1–15 and
20–34 of the CLN3 protein sequence. The antiserum was
afﬁnity-puriﬁed against the N-terminal peptide and used at
1:1000 dilution. Secondary antibodies used were Alexa488
and Alexa555 conjugates (Invitrogen) appropriate to the pri-
maries. Each was used at 1:500 dilution from a stock diluted
1:1 in PBS:glycerol. DNA was visualized by incubating with
ToPro3 1:35 000 (Invitrogen) for 10 min.
Histology and microscopy
Adult eyes, thorax and abdomen. Flies were placed in 1.5 ml
tubes and snap-frozen in liquid N2. After thawing, the ﬂies
were photographed using an Olympus DP71 camera
mounted on a Leica MZ16 stereo microscope using ambient
light to minimize glare.
Adult wings. Wings were removed at the hinge, transferred to
100% isopropanol and then to 1:1 isopropanol:glycerol. After
equilibration, they were mounted in a 1:1 glycerol:lactic acid
solution on slides. Images were taken on a SpotRT digital
camera mounted on Zeiss AxioPlan2 upright microscope.
Immunoﬂuorescence. Images were captured using a Zeiss
LSM510 laser scanning confocal microscope. Sequential scan-
ning was used in all examples to prevent bleed through.
HEK293 cells were imaged with a  63 1.4 NA oil immersion
objective, with an optical slice thickness set to 0.7 mm. Serial
optical slices of 5 mm through wing discs were imaged with a
 20 0.5 NA objective.
Images were processed post-collection with LSM (Zeiss),
Velocity (Improvision) and Photoshop (Adobe) software and
ﬁgures prepared with Photoshop. No gamma correction or ﬁl-
tering was applied to images.
Scanning electron microscopy. SEM was performed in the
Centre for Ultrastructural Imaging at Kings College London
by Dr Tony Brain. Samples were ﬁxed and critical point
dried as described in Wolff (66) and then sputter-coated in
gold and imaged using an FEI Quanta 200F microscope oper-
ated at 5 kV in high vacuum mode.
Sections of adult eyes. Fixation, toluene blue staining and
mounting of adult heads were performed according to the pro-
tocol of Dr R. Carthew (Northwestern University) available
online at www.bioprotocols.info. Images were collected with
a6 3   objective as before.
Quantiﬁcation of scutellar macrochaetae. The number of
macrochaetae on the scutellum of each adult ﬂies was
counted. Control genotypes were enGal4/þ and
enGal4;Dl
RF/þ. Flies of genotype enGal4,UAS-CLN3;þ/þ
were compared with enGal4,UAS-CLN3;Dl
RF/þ ﬂies by
Mann–Whitney test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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